John Ducas

4.5k total citations
99 papers, 2.9k citations indexed

About

John Ducas is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John Ducas has authored 99 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Cardiology and Cardiovascular Medicine, 38 papers in Surgery and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John Ducas's work include Acute Myocardial Infarction Research (45 papers), Coronary Interventions and Diagnostics (19 papers) and Cardiac Imaging and Diagnostics (17 papers). John Ducas is often cited by papers focused on Acute Myocardial Infarction Research (45 papers), Coronary Interventions and Diagnostics (19 papers) and Cardiac Imaging and Diagnostics (17 papers). John Ducas collaborates with scholars based in Canada, United States and United Kingdom. John Ducas's co-authors include Richard M. Prewitt, Eric A. Cohen, Neal S. Kleiman, Usha Schick, Shaun G. Goodman, Elliott M. Antman, Nasir Shaikh, Warren J. Cantor, Abhay Divekar and Anatoly Langer and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

John Ducas

95 papers receiving 2.7k citations

Peers

Countries citing papers authored by John Ducas

Since Specialization

Citations

This map shows the geographic impact of John Ducas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Ducas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Ducas more than expected).

Fields of papers citing papers by John Ducas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Ducas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Ducas. The network helps show where John Ducas may publish in the future.

Co-authorship network of co-authors of John Ducas

This figure shows the co-authorship network connecting the top 25 collaborators of John Ducas. A scholar is included among the top collaborators of John Ducas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Ducas. John Ducas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Using the Zwolle Risk Score at Time of Coronary Angiography to Triage Patients With ST‐Elevation Myocardial Infarction Following Primary Percutaneous Coronary Intervention or Thrombolysis 2022 ·Journal of the American Heart Association ·(unknown), L. Avery, Brett Hiebert, Shuangbo Liu, Kunal Minhas, John Ducas	4
2	Reducing Delay to Treatment of ST-Elevation Myocardial Infarction With Software Electrocardiographic Interpretation and Transmission (SCINET) 2020 ·CJC Open ·(unknown), Christopher Hayes, John Ducas, David W. Allen	3
3	Long-term Follow-up of the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) 2018 ·Canadian Journal of Cardiology ·Yaron Arbel, Dennis T. Ko, Andrew T. Yan, Warren J. Cantor, Akshay Bagai, Maria Koh, María Eberg, Mary Tan, David Fitchett, Bjug Borgundvaag, John Ducas, Michael Heffernan, Laurie J. Morrison, Anatoly Langer, Vladimír Džavík, Shamir R. Mehta, Shaun G. Goodman	9
4	Autologous Bone Marrow Stem Cell Therapy in Patients With ST-Elevation Myocardial Infarction: A Systematic Review and Meta-analysis 2017 ·Canadian Journal of Cardiology ·Maya M. Jeyaraman, Rasheda Rabbani, Leslie Copstein, (unknown), (unknown), Hessam H. Kashani, (unknown), Qingdong Guan, Becky Skidmore, Elissavet Kardami, John Ducas, Samer Mansour, Ryan Zarychanski, Ahmed M Abou-Setta	16
5	Efficacy of early invasive management post-fibrinolysis in men versus women with ST-elevation myocardial infarction: A subgroup analysis from Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) 2012 ·American Heart Journal ·(unknown), Warren J. Cantor, Raymond T. Yan, Shamir R. Mehta, Laurie J. Morrison, Michael Heffernan, David Fitchett, Vladimír Džavík, John Ducas, Bjug Borgundvaag, Eric A. Cohen, Shaun G. Goodman, Andrew T. Yan	9
6	Relationship between risk stratification at admission and treatment effects of early invasive management following fibrinolysis: insights from the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) 2011 ·European Heart Journal ·Andrew T. Yan, Raymond T. Yan, Warren J. Cantor, Bjug Borgundvaag, Eric A. Cohen, David Fitchett, Vladimír Džavík, John Ducas, Mary Tan, Amparo Casanova, Shaun G. Goodman, (unknown)	28
7	Dynamic Compression of the Left Main Coronary Artery by the Left Atrium 2009 ·Journal of Thoracic Imaging ·Robin Ducas, Davinder S. Jassal, Iain D. C. Kirkpatrick, Darren H. Freed, Shelley Zieroth, John Ducas	2
8	Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment 2006 ·Gene Therapy ·Duncan J. Stewart, Adrian Hilton, Jennifer M. Arnold, Jean‐Claude Grégoire, Alain Rivard, Stephen L. Archer, François Charbonneau, Eric A. Cohen, Michael Curtis, Christopher E. Buller, Farrell O. Mendelsohn, Nabil Dib, Pierre Pagé, John Ducas, Sylvain Planté, John A. Sullivan, Jennifer Macko, Camilla Rasmussen, (unknown), Henrik Rasmussen, (unknown)	194
9	Ibutilide Pretreatment to Facilitate Cardioversion of Refractory Atrial Fibrillation in a Patient with Morbid Obesity 2006 ·The Canadian Journal of Hospital Pharmacy ·(unknown), John Ducas	1
10	Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal 2006 ·Catheterization and Cardiovascular Interventions ·Warren J. Cantor, Kenneth W. Mahaffey, Zhen Huang, Pranab Das, Dietrich C. Gulba, Stanislav Glezer, Richard L. Gallo, John Ducas, Marc Cohen, Elliott M. Antman, Anatoly Langer, Neal S. Kleiman, Harvey D. White, Robert J. Chisholm, Robert A. Harrington, James J. Ferguson, Robert M. Califf, Shaun G. Goodman	90
11	Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder 2005 ·Journal of the American College of Cardiology ·Abhay Divekar, (unknown), Nasir Shaikh, (unknown), John Ducas	180
12	A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stenting. 2004 ·PubMed ·Mina Madan, Marino Labinaz, (unknown), (unknown), (unknown), Peter H. Seidelin, John Ducas, (unknown), (unknown), KS Pieper, (unknown), (unknown), (unknown), (unknown), (unknown)	4
13	Percutaneous coronary intervention: cardiogenic shock 2003 ·BMJ ·John Ducas, (unknown)	7
14	Outcome of PTCA and stenting in diabetic and nondiabetic patients: a report from the total occlusion study of Canada (TOSCA) investigators 2002 ·Journal of the American College of Cardiology ·Vladimír Džavík, (unknown), Todd A. Anderson, Eric A. Cohen, John Mancini, Diane Catellier, Gérald Barbeau, John Ducas, Charles Lazzam, Jeffrey R. Burton, Peter B. Berger, Christopher E. Buller	1
15	Effect of a Mechanical vs a Pharmacologic Increase in Aortic Pressure on Coronary Blood Flow and Thrombolysis Induced by IV Administration of a Thrombolytic Agent 1997 ·CHEST Journal ·Richard M. Prewitt, (unknown), Usha Schick, John Ducas	6
16	Influence of walking volume on health benefits in women post-menopause 1996 ·Medicine & Science in Sports & Exercise ·(unknown), Barbara J. Naimark, John Ducas, Jo‐Ann V. Sawatzky, (unknown), (unknown), (unknown)	98
17	Optimizing Coronary Thrombolysis With IV Administration of Recombinant Tissue Plasminogen Activator 1996 ·CHEST Journal ·Richard M. Prewitt, Usha Schick, John Ducas	2
18	Intravenous Administration of Recombinant Tissue Plasminogen Activator 1995 ·CHEST Journal ·Richard M. Prewitt, (unknown), Usha Schick, John Ducas	2
19	Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent 1994 ·Journal of the American College of Cardiology ·Richard M. Prewitt, (unknown), Usha Schick, John Ducas	51
20	Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator 1992 ·Journal of the American College of Cardiology ·Richard M. Prewitt, (unknown), (unknown), John Ducas	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact